Kendall Capital Management

Position in UTHR — UNITED THERAPEUTICS Corp

CIK 1731372 ROCKVILLE, MD

Position in UTHR

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$3,186,502

-$538,005 QoQ

Shares Held

5,881

-6.4% QoQ

Ownership

0.014%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#306

of 870 holders

Holding Since

Jun 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Kendall Capital Management holds $9,113,830 across 5 Drug Manufacturers - Specialty & Generic names. UTHR ranks #2 (35.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VTRS	Viatris Inc	217,370	$3,451,835
2	UTHR	UNITED THERAPEUTICS Corp This page	5,881	$3,186,502
3	COLL	Collegium Pharmaceutical, Inc	34,730	$1,257,226
4	ANIP	Ani Pharmaceuticals Inc	7,395	$612,158
5	AMRX	Amneal Pharmaceuticals, Inc.	35,015	$606,109

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,186,502	5,881	-6.4%	Shares	Sole	2026-08-12
2026-03-31	$3,724,507	6,281	-4.2%	Shares	Sole	2026-04-24
2025-12-31	$3,195,872	6,559	-8.3%	Shares	Sole	2026-01-16
2025-09-30	$2,997,351	7,150	-0.4%	Shares	Sole	2025-11-13
2025-06-30	$2,063,173	7,180	-1.2%	Shares	Sole	2025-07-16
2025-03-31	$2,241,122	7,270	+7.0%	Shares	Sole	2025-04-25
2024-12-31	$2,397,547	6,795	+3.9%	Shares	Sole	2025-02-07
2024-09-30	$2,344,325	6,542	+5.5%	Shares	Sole	2024-11-08
2024-06-30	$1,975,647	6,202	+9.7%	Shares	Sole	2024-08-12
2024-03-31	$1,298,377	5,652	+34.2%	Shares	Sole	2024-05-10
2023-12-31	$926,176	4,212	+45.1%	Shares	Sole	2024-01-26
2023-09-30	$655,474	2,902	+115.8%	Shares	Sole	2023-10-31
2023-06-30	$296,908	1,345	—	Shares	Sole	2023-07-28
No filing history on record for this holder in this stock.